Skip to main content

Advertisement

Table 1 Baseline demographic and clinical characteristics of the participants

From: Health-related quality of Life in patients with chronic hepatitis C receiving Sofosbuvir-based treatment, with and without Interferon: a prospective observational study in Egypt

  Number (total 62) Percent
Age 54.06 ± 10.41*
Gender
 • Males 30 48.40
 • Females 32 51.60
Education
 • Uneducated 24 38.70
 • Can read and write or preparatory 12 29.00
 • Secondary 12 19.40
 • University 8 12.90
Marital status
 • Unmarried 17 27.40
 • Married 45 72.60
Employment status
 • Unemployed 17 27.40
 • Employed 17 27.40
 • Housewife 28 45.20
Residence area
 • Rural 15 24.20
 • Urban 47 75.80
Diseases stage
 • Non cirrhotic 31 50
 • Cirrhotic 31 50
Number of comorbidities
 • 0 31 50
 • 1 17 27.4
 • 2 11 17.7
 • 3 3 4.8
Type of comorbidity
 • Hypertension 15 24.20
 • Diabetes 19 30.60
 • Others (renal disease, disc, heart disease, asthma, peptic ulcer) 11 17.70
Disease duration (Range from 3 to 216 months) 71.10 ± 57.72*
Type of treatment
 • Dual 31 50
 • Triple 31 50
Treatment experience
 • Naive 54 87.10
 • Experienced 8 12.90
Treatment paying method
 • Self 6 9.70
 • Governmental 56 90.30
BMI
 T0 30.6 ± 4.24*
 T1 30.4 ± 4.53*
PCR at T1 (50 cases)
 • Negative 32 64
 • Positive 18 36
  1. BMI body mass index, PCR Polymerase Chain Reaction, T0 Time 0, T1 time 1
  2. *Mean ± SD
  3. *P value: * ≤ .05 at two tailed